Genprex
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $23 | $0 |
Gross Profit | -2 | -2 | |
EBITDA | -6,515 | -5,994 | |
EBIT | -6,518 | -5,996 | |
Net Income | -6,495 | -5,968 | -5,929 |
Net Change In Cash | 0 | 23 | 0 |
Free Cash Flow | -5,778 | -5,314 | -4,973 |
Cash | 2,459 | 8,217 | 6,737 |
Basic Shares | 2,161 | 1,618 | 1,485 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15 | -23,830 | -22 | -22 |
EBITDA | -31,060 | -23,805 | -20,647 | -17,938 |
EBIT | -31,075 | -23,830 | -20,670 | -17,961 |
Net Income | -30,860 | -29,463 | -19,590 | -17,923 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 25,317 | |||
Free Cash Flow | -24,809 | -17,838 | -14,368 | -16,272 |
Cash | 6,737 | 20,954 | 38,628 | 27,319 |
Basic Shares | 1,367 | 1,198 | 1,177 | 888 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.23 |
2024-06-30 | -$3 |
2024-03-31 | -$3.69 |
2023-12-31 | -$3.96 |
